Efficacy of a Lipolytic Cream in an Overweight and Obesity Treatment
1 other identifier
interventional
102
0 countries
N/A
Brief Summary
The coadyouvant efficacy of a combination of cosmetics ingredients in the form of a lipolytic cream with hypocaloric diet and physical activity were assessed and compared with with hypocaloric diet and physical activity for overweight and obesity treatment in patients.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Jun 2016
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2016
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 21, 2018
CompletedStudy Completion
Last participant's last visit for all outcomes
September 23, 2018
CompletedFirst Submitted
Initial submission to the registry
September 24, 2018
CompletedFirst Posted
Study publicly available on registry
October 26, 2018
CompletedOctober 26, 2018
October 1, 2018
2.3 years
September 24, 2018
October 24, 2018
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Change in body composition with a scientific impedanciometer
Body fat in kilograms and percentage variation measured with an impendaciometer (Tanita MC780)
Baseline and weeks: 1, 4, 8, 12,16
Secondary Outcomes (1)
Change in perimeters measured with measuring tape
Baseline and weeks: 1, 4, 8, 12,16
Study Arms (2)
LC
ACTIVE COMPARATORLypolitic cream with hypocaloric diet and physicial activity in 51 patients
NLC
PLACEBO COMPARATORHypocaloric diet and physicial activity alone in 51 patients
Interventions
Eligibility Criteria
You may qualify if:
- Overweight and obesity treatment voluntary assistance
You may not qualify if:
- Hearth disease
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- BiomediKcallead
- University of Alicantecollaborator
- Universidad Miguel Hernandez de Elchecollaborator
- Universidad Simón Bolívarcollaborator
Related Publications (3)
Byun SY, Kwon SH, Heo SH, Shim JS, Du MH, Na JI. Efficacy of Slimming Cream Containing 3.5% Water-Soluble Caffeine and Xanthenes for the Treatment of Cellulite: Clinical Study and Literature Review. Ann Dermatol. 2015 Jun;27(3):243-9. doi: 10.5021/ad.2015.27.3.243. Epub 2015 May 29.
PMID: 26082579RESULTEscudier B, Fanchon C, Labrousse E, Pellae M. Benefit of a topical slimming cream in conjunction with dietary advice. Int J Cosmet Sci. 2011 Aug;33(4):334-7. doi: 10.1111/j.1468-2494.2010.00630.x. Epub 2011 Feb 1.
PMID: 21284660RESULTSalavert M, Amarger S, Le Bouedec MC, Roger H, Souteyrand P, D'incan M. Allergic contact dermatitis to guggul in a slimming cream. Contact Dermatitis. 2007 May;56(5):286-7. doi: 10.1111/j.0105-1873.2006.00885.x. No abstract available.
PMID: 17441853RESULT
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Masking Details
- Researchers assessed the efficacy of a lipolytic cream with hypocaloric diet and physical activity in the treatment of overweight and obesity. The control treatment was lypolitic cream with hypocaloric diet and physicial activity and hypocaloric diet and physicial activity alone. In total, 102 patients were recruited and allocated to treatment (51: lypolitic cream with hypocaloric diet and physicial activity and, 51: hypocaloric diet and physicial activity alone.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
September 24, 2018
First Posted
October 26, 2018
Study Start
June 1, 2016
Primary Completion
September 21, 2018
Study Completion
September 23, 2018
Last Updated
October 26, 2018
Record last verified: 2018-10
Data Sharing
- IPD Sharing
- Will share
- Shared Documents
- SAP, ICF
Anonymous patient information will be shared only if requested and justified in writing by researchers. It will be evaluated in committee if it is a justified request.